Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Cedars-Sinai Medical Center
Northside Hospital, Inc.
Thomas Jefferson University
University of Liege
H. Lee Moffitt Cancer Center and Research Institute
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Illinois at Chicago
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indiana University
Texas Oncology Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
M.D. Anderson Cancer Center